Register

Register with Afluria.com to be able to create pre-book orders and receive information and updates. You must register as a Health Care Professional if you intend to place a pre-book order for Afluria^®.



I am a: *
First Name: *
Last Name: *
This is my: *	Home address Work address
Address 1: *
Address 2:
City: *
State: *
Zip: *
Telephone: *	() -
Fax:	() -
To Sign In to Afluria.com, you will need to provide your e-mail address and choose a password.
E-mail: *
Confirm E-mail: *
Password: *
Retype Password: *


I would like to be contacted periodically with information about Afluria^® and special offers from CSL Biotherapies. You must opt-in to receive information from CSL Biotherapies so we can contact you about your pre-book order. Prior to submitting your information, please review our Privacy Policy.


* Required information

Important Safety Information

Afluria^® is indicated for active immunization of persons 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. The indication is based on the immune response elicited by Afluria^®; no controlled clinical studies have demonstrated a decrease in influenza disease after vaccination with Afluria^®.

Afluria^® should not be administered to individuals with hypersensitivity to eggs or chicken protein or other components of Afluria^®, or to anyone who has had a life-threatening reaction to previous influenza vaccination. The most common injection-site adverse reactions were tenderness, pain, redness, and swelling. The most common systemic adverse reactions were headache, malaise, and muscle aches.

Vaccination with Afluria^® may not protect all individuals. Immunocompromised persons may have a diminished immune response. If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to give Afluria^® should be based on careful consideration of the potential benefits and risks.

Click here for full PRESCRIBING INFORMATION.